Predictors of relapse in major depression
Part of Mental health clinical trials.
This study looks at adults with major depressive disorder who have responded to treatment, to find out what might predict a relapse. You will wear a wrist activity monitor and complete questionnaires.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have been diagnosed with major depressive disorder (MDD).
- Your current or most recent episode of depression has responded to treatment (or you are in remission as of May 2023).
- You are willing to wear a wrist-worn activity tracker for the whole study.
- You can read and understand English well enough to complete surveys.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at brain and genetic markers to understand why depression returns. It is for people with major depression who are not currently taking medication.
This study explores how city living and daily stress affect depression, anxiety, and alcohol use disorders by having you wear a monitoring wristband and use a smartphone app to track your physical responses. Researchers hope to better understand the link between environmental stress and mental health symptoms.
This study tracks your daily rest and activity patterns over time to see if changes in your sleep-wake cycle can predict future depression. It could help develop better early warning systems for depression.
This study is collecting detailed information from people with depression and from healthy volunteers to better understand the biological factors involved. Participants will provide samples and complete assessments to help researchers identify new ways to diagnose and treat depression.
This study checks whether your answers on a depression questionnaire can predict the chance of depression coming back after you leave the hospital. If it works, it may help doctors spot relapse risk earlier and plan follow-up care.
This study looks at treatment response markers (signs in the body) in people with major depressive disorder (MDD). It may help researchers understand who is more likely to benefit from antidepressant treatment.
Hear when a new Major Depressive Disorder (MDD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.